Hematological Genetic Testing

Identify actionable mutations to guide targeted therapy.

Connect with our experts

To Book a test

call : +91 75691 32891

What is Hematological Genetic Testing?

In hematological malignancies, genetic testing is performed on blood, bone marrow aspirates, or lymph node samples. It focuses on identifying chromosomal translocations, gene fusions, somatic mutations, and clonal abnormalities that define specific disease subtypes.

Which Hematological panels do we offer?

  • Acute Leukemia Reflex Panel
  • ALL Multiplex PCR Panel
  • AML Multiplex Advanced
  • MPN Reflex Panel
  • CLL Panel
  • PCR BCR-ABL1 Qualitative Assay
  • PCR PML-RARA t(15;17) Qualitative Assay
  • Myeloid gene panel

Who can consider Hematological malignancies testing?

  • Suspected cases of leukemia, lymphoma, or multiple myeloma
  • Unexplained cytopenias or persistent leukocytosis
  • Abnormal peripheral smear or bone marrow findings
  • To guide targeted therapy and treatment decisions
  • Disease progression or relapse evaluation (resistance mutation detection)
  • Monitoring measurable residual disease (MRD)

Key Parameters covered under the panels

Connect with our expert

Why choose OneDNA

Comprehensive Coverage

Comprehensive testing across both molecular and cytogenetic platforms

Accredited Laboratories

NABL & CAP accredited lab

Support & Care

End-to-end support including genetic counselling and report guidance.

Early & Accurate

High accuracy with advanced technologies and stringent quality controls

Get our brochure

Download our brochure to learn more about Hematological Genetic Testing

Frequently Asked Questions

It plays a big role in treatment. Certain genetic findings help doctors choose targeted therapies that are more effective and sometimes less toxic than standard treatments.

Not at all. Genetic testing is often useful during and after treatment as well, especially to monitor response and detect any residual disease early.

Not necessarily. Mutations help doctors understand the disease better, they’re used to guide treatment, not just indicate severity.

Yes. It can detect very small amounts of disease, helping doctors understand how well the treatment is working.

It doesn’t change the disease itself, but it helps doctors choose more precise and effective treatments, which can improve outcomes.

Some Blogs from us

Folate Receptor Autoantibodies in Autism Spectrum Disorder

Sudden Cardiac Arrest: A Growing Health Crisis in India

Sudden cardiac arrest (SCA) is one of the most devastating cardiovascular emergencies. SCA happens when the electrical system of the heart malfunctions, resulting in deadly arrhythmias, as opposed to a heart attack, which is brought on by limited blood supply to the heart muscle.

Genetic Keys to Cracking Testicular Cancer

Testicular cancer is a highly treatable form of cancer that develops in the testicles, which are the male reproductive glands responsible for producing sperm and testosterone.

Our Companies

Screens for 90+ conditions

Get in touch

Have questions or need assistance? Get in touch with our team—we’re here to help.

Fill out the form below to get instant access to the product brochure.